Literature DB >> 11549774

Update on tumor cell procoagulant factors.

A J Gale1, S G Gordon.   

Abstract

Tumor cells produce tissue factor, cancer procoagulant, plasminogen activators and other factors that interact with the coagulation system, the fibrinolytic system and vascular or blood cells such that they can upset the normal homeostasis and balance between activation and inhibition of the coagulation and fibrinolytic systems. These activities play a role in tumor cell growth and metastasis, vascular wall function, and hemostasis. Proteases and their inhibitors are intimately involved in all aspects of the hemostatic, cell proliferation and cellular signalling systems. This review provides a brief examination of recent observations in this complex interaction of cellular and hemostatic factors. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549774     DOI: 10.1159/000046586

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  20 in total

1.  Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

Authors:  Harold D Love; S Erin Booton; Braden E Boone; Joan P Breyer; Tatsuki Koyama; Monica P Revelo; Scott B Shappell; Jeffrey R Smith; Simon W Hayward
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

Review 2.  Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.

Authors:  Annalisa Contursi; Angela Sacco; Rosalia Grande; Melania Dovizio; Paola Patrignani
Journal:  Cell Mol Life Sci       Date:  2017-05-09       Impact factor: 9.261

Review 3.  Medical management of patients with brain tumors.

Authors:  Patrick Y Wen; David Schiff; Santosh Kesari; Jan Drappatz; Debra C Gigas; Lisa Doherty
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

4.  D-dimer measured at first venous thromboembolism is associated with future risk of cancer.

Authors:  Olga V Gran; Sigrid K Brækkan; Benedikte Paulsen; Hanne Skille; John-Bjarne Hansen
Journal:  Haematologica       Date:  2016-09-09       Impact factor: 9.941

5.  Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

Authors:  Yue-Zu Fan; Wei Sun
Journal:  World J Gastrointest Surg       Date:  2010-04-27

6.  Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.

Authors:  Aydan Eroglu; Arzu Ulu; Ragip Cam; Cengiz Kurtman; Nejat Akar
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

7.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

8.  Acute thrombosis in superior mesenteric artery as first symptom in a AML patient.

Authors:  Yan Liu; Xangshan Chao; Weiying Gu; Xiaoying Hua; Ning Xu
Journal:  Int J Gen Med       Date:  2008-11-30

9.  [Superior vena cava syndrome with bilateral jugular and subclavian vein thrombosis. Paraneoplastic manifestion of renal cell carcinoma].

Authors:  M May; M Seehafer; C Helke; T Uberrück; S Gunia; B Hoschke
Journal:  Urologe A       Date:  2003-10       Impact factor: 0.639

10.  Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response.

Authors:  Hiroharu Yamashita; Joji Kitayama; Masataka Taguri; Hirokazu Nagawa
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.